HYDROCODONE BITARTRATE AND IBUPROFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocodone Bitartrate And Ibuprofen, and what generic alternatives are available?
Hydrocodone Bitartrate And Ibuprofen is a drug marketed by Actavis Labs Fl Inc, Amneal Pharms Ny, Ani Pharms, Aurolife Pharma Llc, Nostrum Labs Inc, Sun Pharm Inds Inc, and Teva. and is included in seven NDAs.
The generic ingredient in HYDROCODONE BITARTRATE AND IBUPROFEN is hydrocodone bitartrate; ibuprofen. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate; ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrocodone Bitartrate And Ibuprofen
A generic version of HYDROCODONE BITARTRATE AND IBUPROFEN was approved as hydrocodone bitartrate; ibuprofen by ACTAVIS LABS FL INC on December 31st, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE BITARTRATE AND IBUPROFEN?
- What are the global sales for HYDROCODONE BITARTRATE AND IBUPROFEN?
- What is Average Wholesale Price for HYDROCODONE BITARTRATE AND IBUPROFEN?
Summary for HYDROCODONE BITARTRATE AND IBUPROFEN
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 1 |
| Patent Applications: | 193 |
| DailyMed Link: | HYDROCODONE BITARTRATE AND IBUPROFEN at DailyMed |
Recent Clinical Trials for HYDROCODONE BITARTRATE AND IBUPROFEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cephalon | Phase 1 |
See all HYDROCODONE BITARTRATE AND IBUPROFEN clinical trials
Pharmacology for HYDROCODONE BITARTRATE AND IBUPROFEN
| Drug Class | Nonsteroidal Anti-inflammatory Drug Opioid Agonist |
| Mechanism of Action | Cyclooxygenase Inhibitors Opioid Agonists |
